fluorodeoxyglucose f18 has been researched along with tamoxifen in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Harju-Jeanty, R; Kangas, L; Kellokumpu-Lehtinen, P; Paul, R; Tuominen, J | 1 |
| d'Argy, R; Frankenberg, L; Haaparanta, M; Halldin, C; Kangas, L; Lundqvist, H; Någren, K; Paul, R; Roeda, D; Stålnacke, CG | 1 |
| Dehdashti, F; Flanagan, FL; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Welch, MJ | 1 |
| Dehdashti, F; Katzenellenbogen, JA; Mortimer, JE; Siegel, BA; Trinkaus, K; Welch, MJ | 1 |
| Jacene, HA; Stearns, V; Wahl, RL | 1 |
| Bénard, F; Langlois, MF; Leboeuf, R | 1 |
| Fujibayashi, Y; Kobayashi, M; Mori, T; Okazawa, H; Tsuchida, T; Tsujikawa, T; Yoshida, Y | 1 |
| Han, SH; Hendriksz, TR; Huiskes, AW; Jansen, I; van Bommel, EF | 1 |
| Cagnolini, A; Gruaz-Guyon, A; Lantry, LE; Montravers, F; Nataf, V; Nunn, AD; Prignon, A; Provost, C; Talbot, JN | 1 |
| Fujimoto, Y; Fukushima, K; Higuchi, T; Imamura, M; Kitajima, K; Miyagawa, Y; Miyoshi, Y; Murase, K; Nishimukai, A; Ozawa, H; Takatsuka, Y; Yanai, A | 1 |
| Chen, P; He, W; Li, J; Ouyang, R; Peng, H; Zong, D | 1 |
| Bal, A; Bhatia, A; Chadha, V; Chhabra, A; Kaur, K; Kumar, R; Laroiya, I; Mittal, BR; Sharma, U; Shukla, J; Singh, G; Upadhyay, D; Vatsa, R | 1 |
1 review(s) available for fluorodeoxyglucose f18 and tamoxifen
| Article | Year |
|---|---|
Concurrent benign metastasizing leiomyoma in the lung and lumbar spine with elevated standardized uptake value level in positron-emission tomography computed tomography: A case report and literature review.
Topics: Diagnosis, Differential; Estrogen Antagonists; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Lumbar Vertebrae; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Spinal Neoplasms; Tamoxifen; Uterine Neoplasms | 2018 |
2 trial(s) available for fluorodeoxyglucose f18 and tamoxifen
| Article | Year |
|---|---|
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Receptors, Estrogen; Tamoxifen; Tomography, Emission-Computed | 2001 |
(18)F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.
Topics: Acute-Phase Proteins; Aged; Antineoplastic Agents, Hormonal; Disease Progression; Drug Monitoring; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Recurrence; Regression Analysis; Retroperitoneal Fibrosis; Tamoxifen; Tomography, X-Ray Computed | 2010 |
9 other study(ies) available for fluorodeoxyglucose f18 and tamoxifen
| Article | Year |
|---|---|
Rats with mammary cancer treated with toremifene and interferon: morphometry and needle aspiration biopsy for determination of ATP and 14C-fluorodeoxyglucose content.
Topics: Adenosine Triphosphate; Animals; Biopsy, Needle; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Interferon-gamma; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Recombinant Proteins; Tamoxifen; Toremifene | 1989 |
Comparative double-tracer whole-body autoradiography: uptake of 11C-, 18F- and 3H-labeled compounds in rat tumors.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Carcinoma 256, Walker; Deoxy Sugars; Deoxyglucose; Estrogen Antagonists; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Methionine; Rats; Rats, Inbred Strains; Tamoxifen; Thymidine; Tissue Distribution; Toremifene; Tritium | 1988 |
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Estrogen; Tamoxifen; Time Factors; Tomography, Emission-Computed; Treatment Outcome | 1999 |
Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.
Topics: Abdomen; Acute Disease; Adult; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Chemotherapy, Adjuvant; Combined Modality Therapy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Hepatitis C; Humans; Lymphatic Diseases; Lymphatic Metastasis; Mastectomy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Spinal Neoplasms; Spleen; Tamoxifen; Thoracic Vertebrae; Tomography, X-Ray Computed | 2006 |
Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Topics: Adrenal Gland Neoplasms; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Papillary; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Estrogens; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Iodine Radioisotopes; Lung Neoplasms; Mastectomy, Segmental; Mediastinal Neoplasms; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thyroid Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Distinctive FDG and FES accumulation pattern of two tamoxifen-treated patients with endometrial hyperplasia.
Topics: Aged; Aged, 80 and over; Endometrial Hyperplasia; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tamoxifen; Tissue Distribution | 2008 |
(68)Ga-AMBA and (18)F-FDG for preclinical PET imaging of breast cancer: effect of tamoxifen treatment on tracer uptake by tumor.
Topics: Animals; Biological Transport; Breast Neoplasms; Cell Proliferation; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Mice; Oligopeptides; Positron-Emission Tomography; Tamoxifen; Tumor Burden | 2015 |
Prognostic significance of preoperative
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gonadotropin-Releasing Hormone; Humans; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Preoperative Period; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Tamoxifen; Tumor Burden | 2016 |
Tc-99m-tamoxifen: A novel diagnostic imaging agent for estrogen receptor-expressing breast cancer patients.
Topics: Animals; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Rats; Receptors, Estrogen; Tamoxifen; Technetium; Tissue Distribution | 2022 |